187 related articles for article (PubMed ID: 34694277)
21. Unique vaginal microbiota that includes an unknown Mycoplasma-like organism is associated with Trichomonas vaginalis infection.
Martin DH; Zozaya M; Lillis RA; Myers L; Nsuami MJ; Ferris MJ
J Infect Dis; 2013 Jun; 207(12):1922-31. PubMed ID: 23482642
[TBL] [Abstract][Full Text] [Related]
22. Antibiotics for bacterial vaginosis or Trichomonas vaginalis in pregnancy: a systematic review.
Okun N; Gronau KA; Hannah ME
Obstet Gynecol; 2005 Apr; 105(4):857-68. PubMed ID: 15802417
[TBL] [Abstract][Full Text] [Related]
23. Clinical importance of detection of bacterial vaginosis, trichomonas vaginalis, candida albicans and actinomyces in Papanicolaou smears.
Güdücü N; Gönenç G; Işçi H; Yiğiter AB; Başsüllü N; Dünder I
Clin Exp Obstet Gynecol; 2012; 39(3):333-6. PubMed ID: 23157037
[TBL] [Abstract][Full Text] [Related]
24. Co-occurrence of Trichomonas vaginalis and bacterial vaginosis among HIV-positive women.
Gatski M; Martin DH; Clark RA; Harville E; Schmidt N; Kissinger P
Sex Transm Dis; 2011 Mar; 38(3):163-6. PubMed ID: 20842073
[TBL] [Abstract][Full Text] [Related]
25. Co-occurrence of Trichomonas vaginalis and bacterial vaginosis and vaginal shedding of HIV-1 RNA.
Fastring DR; Amedee A; Gatski M; Clark RA; Mena LA; Levison J; Schmidt N; Rice J; Gustat J; Kissinger P
Sex Transm Dis; 2014 Mar; 41(3):173-9. PubMed ID: 24521723
[TBL] [Abstract][Full Text] [Related]
26. Bacterial vaginosis and the risk of trichomonas vaginalis acquisition among HIV-1-negative women.
Balkus JE; Richardson BA; Rabe LK; Taha TE; Mgodi N; Kasaro MP; Ramjee G; Hoffman IF; Abdool Karim SS
Sex Transm Dis; 2014 Feb; 41(2):123-8. PubMed ID: 24413493
[TBL] [Abstract][Full Text] [Related]
27. Patient-delivered partner treatment and Trichomonas vaginalis repeat infection among human immunodeficiency virus-infected women.
Gatski M; Mena L; Levison J; Clark RA; Henderson H; Schmidt N; Rosenthal SL; Martin DH; Kissinger P
Sex Transm Dis; 2010 Aug; 37(8):502-5. PubMed ID: 20502393
[TBL] [Abstract][Full Text] [Related]
28. Novel metronidazole-chalcone conjugates with potential to counter drug resistance in Trichomonas vaginalis.
Anthwal A; Rajesh UC; Rawat MS; Kushwaha B; Maikhuri JP; Sharma VL; Gupta G; Rawat DS
Eur J Med Chem; 2014 May; 79():89-94. PubMed ID: 24727243
[TBL] [Abstract][Full Text] [Related]
29. Single-dose versus multidose metronidazole for the treatment of vaginal trichomoniasis: A meta-analysis.
OuYang Z; Wu J; Xu Y; Wei S; Zhong B; Zhang M; Li F
Eur J Obstet Gynecol Reprod Biol; 2020 Dec; 255():56-62. PubMed ID: 33080486
[TBL] [Abstract][Full Text] [Related]
30. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population.
Krashin JW; Koumans EH; Bradshaw-Sydnor AC; Braxton JR; Evan Secor W; Sawyer MK; Markowitz LE
Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis, Treatment, Follow-up, and Persistence of Trichomonas vaginalis in Women 45 Years and Older According to HIV Status: A 10-Year Retrospective Cohort.
Lazenby GB; Hill A; Tarleton J; Soper D
Sex Transm Dis; 2020 May; 47(5):332-337. PubMed ID: 32149959
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the Effect of Vaginal Zataria multiflora Cream and Oral Metronidazole Pill on Results of Treatments for Vaginal Infections including Trichomoniasis and Bacterial Vaginosis in Women of Reproductive Age.
Abdali K; Jahed L; Amooee S; Zarshenas M; Tabatabaee H; Bekhradi R
Biomed Res Int; 2015; 2015():683640. PubMed ID: 26266260
[TBL] [Abstract][Full Text] [Related]
33. Health gains from screening for infection of the lower genital tract in women attending for termination of pregnancy.
Blackwell AL; Thomas PD; Wareham K; Emery SJ
Lancet; 1993 Jul; 342(8865):206-10. PubMed ID: 8100930
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of netropsin dihydrochloride against the viability, cytopathogenicity and hemolytic activity of Trichomonas vaginalis clinical isolates.
Abou Gamra MM; Kamel HH; Ezz Eldin HM; Taha Zahran FM
J Infect Chemother; 2019 Dec; 25(12):955-964. PubMed ID: 31189504
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of single-dose oral secnidazole for the treatment of trichomoniasis in women co-infected with trichomoniasis and bacterial vaginosis: a post hoc subgroup analysis of phase 3 clinical trial data.
Muzny CA; Van Gerwen OT; Kaufman G; Chavoustie S
BMJ Open; 2023 Aug; 13(8):e072071. PubMed ID: 37550019
[TBL] [Abstract][Full Text] [Related]
36. Affirm VPIII microbial identification test can be used to detect gardnerella vaginalis, Candida albicans and trichomonas vaginalis microbial infections in Korean women.
Byun SW; Park YJ; Hur SY
J Obstet Gynaecol Res; 2016 Apr; 42(4):422-6. PubMed ID: 26787446
[TBL] [Abstract][Full Text] [Related]
37. A case of metronidazole-resistant Trichomonas vaginalis in pregnancy.
Forbes GL; Drayton R; Forbes GD
Int J STD AIDS; 2016 Sep; 27(10):906-8. PubMed ID: 26384945
[TBL] [Abstract][Full Text] [Related]
38. Higher vaginal pH in Trichomonas vaginalis infection with intermediate Nugent score in reproductive-age women-a hospital-based cross-sectional study in Odisha, India.
Das P; Swain T; Mohanty JR; Sinha S; Padhi B; Torondel B; Cumming O; Panda B; Nayak A; Panigrahi P
Parasitol Res; 2018 Sep; 117(9):2735-2742. PubMed ID: 29936622
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial.
Bradshaw CS; Pirotta M; De Guingand D; Hocking JS; Morton AN; Garland SM; Fehler G; Morrow A; Walker S; Vodstrcil LA; Fairley CK
PLoS One; 2012; 7(4):e34540. PubMed ID: 22509319
[TBL] [Abstract][Full Text] [Related]
40. Nanoliposomes increases Anti-Trichomonas vaginalis and apoptotic activities of metronidazole.
Ebrahimi M; Montazeri M; Ahmadi A; Nami S; Hamishehkar H; Shahrivar F; Bakhtiar NM; Nissapatorn V; Spotin A; Ahmadpour E
Acta Trop; 2021 Dec; 224():106156. PubMed ID: 34599888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
